Finally, our findings suggest that NE-THCQ may inhibit renal fibrosis progression mainly by regulating the inflammatory process, reversing EMT and decreasing ECM deposition through PI3K/AKT/mTOR and HIF-1α/VEGF signaling pathways. The gene discussed is VEGFA; the disease is renal fibrosis.